Advanced Enzyme Technologies is currently trading at Rs. 218.65, up by 2.45 points or 1.13% from its previous closing of Rs. 216.20 on the BSE.
The scrip opened at Rs. 218.00 and has touched a high and low of Rs. 219.25 and Rs. 217.00 respectively. So far 4588 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 361.00 on 11-Jul-2017 and a 52 week low of Rs. 205.30 on 06-Jun-2018.
Last one week high and low of the scrip stood at Rs. 219.25 and Rs. 208.50 respectively. The current market cap of the company is Rs. 2413.85 crore.
The promoters holding in the company stood at 71.32%, while Institutions and Non-Institutions held 7.19% and 21.49% respectively.
Advanced Enzyme Technologies has completed the additional investment of (Malaysian Ringgit) MYR 100,000 (around Rs 17 lakh) by way of subscription to the Right Issue of 100,000 equity shares having face value of MYR 1 each of the company’s subsidiary -- Advanced Enzymes (Malaysia) Sdn. Bhd.
In view of the aforesaid, the paid-up share capital of AEM has increased from existing MYR 400,000 to MYR 500,000.
Advanced Enzyme Technologies is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: